Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Etzer Darout is an analyst at BMO Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/12/2025 | ARVN | Buy Now | Arvinas | $8.36 | 139.17% | Etzer Darout50% | $82 → $20 | Maintains | Outperform | Get Alert |
| 03/11/2025 | PTGX | Buy Now | Protagonist Therapeutics | $54.25 | 32.72% | Etzer Darout50% | $62 → $72 | Reiterates | Outperform → Outperform | Get Alert |
| 03/11/2025 | BNTX | Buy Now | BioNTech | $98.96 | 44.5% | Etzer Darout50% | $130 → $143 | Maintains | Outperform | Get Alert |
| 02/12/2025 | ARVN | Buy Now | Arvinas | $8.36 | 880.6% | Etzer Darout50% | $88 → $82 | Reiterates | Outperform → Outperform | Get Alert |
| 02/11/2025 | QTTB | Buy Now | Q32 Bio | $2.22 | 35.14% | Etzer Darout50% | $22 → $3 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/10/2025 | IGMS | Buy Now | IGM Biosciences | $1.21 | 65.98% | Etzer Darout50% | $21 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/20/2024 | EXEL | Buy Now | Exelixis | $36.36 | 10.01% | Etzer Darout50% | $36 → $40 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/12/2024 | QTTB | Buy Now | Q32 Bio | $2.22 | 890.99% | Etzer Darout50% | $64 → $22 | Maintains | Outperform | Get Alert |
| 12/06/2024 | QTTB | Buy Now | Q32 Bio | $2.22 | 2782.88% | Etzer Darout50% | → $64 | Initiates | → Outperform | Get Alert |
| 12/06/2024 | TRML | Buy Now | Tourmaline Bio | $17.33 | 188.52% | Etzer Darout50% | → $50 | Initiates | → Outperform | Get Alert |
| 12/06/2024 | PTGX | Buy Now | Protagonist Therapeutics | $54.25 | 14.29% | Etzer Darout50% | → $62 | Initiates | → Outperform | Get Alert |
| 12/06/2024 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 156.22% | Etzer Darout50% | → $35 | Initiates | → Outperform | Get Alert |
| 12/06/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 61.62% | Etzer Darout50% | → $55 | Initiates | → Market Perform | Get Alert |
| 12/06/2024 | IGMS | Buy Now | IGM Biosciences | $1.21 | 1642.74% | Etzer Darout50% | → $21 | Initiates | → Outperform | Get Alert |
| 12/06/2024 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | 1106.9% | Etzer Darout50% | → $63 | Initiates | → Outperform | Get Alert |
| 11/20/2024 | ARVN | Buy Now | Arvinas | $8.36 | 952.35% | Etzer Darout50% | $90 → $88 | Maintains | Outperform | Get Alert |
| 11/14/2024 | ACRV | Buy Now | Acrivon Therapeutics | $5.36 | 403.73% | Etzer Darout50% | $28 → $27 | Maintains | Outperform | Get Alert |
| 11/13/2024 | NUVL | Buy Now | Nuvalent | $76.66 | 74.8% | Etzer Darout50% | $132 → $134 | Maintains | Outperform | Get Alert |
| 11/08/2024 | XNCR | Buy Now | Xencor | $12.52 | 171.57% | Etzer Darout50% | $32 → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 11/08/2024 | GMAB | Buy Now | Genmab | $20.20 | 137.62% | Etzer Darout50% | $46 → $48 | Reiterates | Outperform → Outperform | Get Alert |
| 10/30/2024 | NVS | Buy Now | Novartis | $112.03 | 7.11% | Etzer Darout50% | $118 → $120 | Maintains | Market Perform | Get Alert |
| 10/30/2024 | EXEL | Buy Now | Exelixis | $36.36 | -0.99% | Etzer Darout50% | $29 → $36 | Maintains | Outperform | Get Alert |
| 10/11/2024 | SRRK | Buy Now | Scholar Rock Holding | $33.88 | 12.16% | Etzer Darout50% | $34 → $38 | Maintains | Outperform | Get Alert |
| 09/16/2024 | TERN | Buy Now | Terns Pharma | $3.16 | 722.78% | Etzer Darout50% | $19 → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 09/16/2024 | NUVL | Buy Now | Nuvalent | $76.66 | 72.19% | Etzer Darout50% | $102 → $132 | Maintains | Outperform | Get Alert |
| 09/16/2024 | ACRV | Buy Now | Acrivon Therapeutics | $5.36 | 422.39% | Etzer Darout50% | $25 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 08/13/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 450.66% | Etzer Darout50% | $26 → $25 | Maintains | Outperform | Get Alert |
| 08/09/2024 | SRRK | Buy Now | Scholar Rock Holding | $33.88 | 0.35% | Etzer Darout50% | $31 → $34 | Maintains | Outperform | Get Alert |
| 08/07/2024 | MGNX | Buy Now | Macrogenics | $2.21 | 126.24% | Etzer Darout50% | $8 → $5 | Maintains | Market Perform | Get Alert |
| 08/06/2024 | XNCR | Buy Now | Xencor | $12.52 | 155.59% | Etzer Darout50% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert |
| 08/06/2024 | TERN | Buy Now | Terns Pharma | $3.16 | 501.27% | Etzer Darout50% | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 08/06/2024 | CCCC | Buy Now | C4 Therapeutics | $2.10 | 852.38% | Etzer Darout50% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 06/14/2024 | XNCR | Buy Now | Xencor | $12.52 | 155.59% | Etzer Darout50% | $34 → $32 | Maintains | Outperform | Get Alert |
| 06/13/2024 | SRRK | Buy Now | Scholar Rock Holding | $33.88 | -8.5% | Etzer Darout50% | $29 → $31 | Maintains | Outperform | Get Alert |
| 06/04/2024 | MRUS | Buy Now | Merus | $46.39 | 96.16% | Etzer Darout50% | $84 → $91 | Maintains | Outperform | Get Alert |
| 05/15/2024 | ACRV | Buy Now | Acrivon Therapeutics | $5.36 | 366.42% | Etzer Darout50% | $25 → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | FATE | Buy Now | Fate Therapeutics | $0.95 | 531.51% | Etzer Darout50% | $7 → $6 | Maintains | Market Perform | Get Alert |
| 05/10/2024 | MGNX | Buy Now | Macrogenics | $2.21 | 261.99% | Etzer Darout50% | $24 → $8 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/09/2024 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 498.33% | Etzer Darout50% | $3.25 → $3.59 | Maintains | Market Perform | Get Alert |
| 05/07/2024 | BNTX | Buy Now | BioNTech | $98.96 | 23.28% | Etzer Darout50% | $123 → $122 | Maintains | Outperform | Get Alert |
| 05/01/2024 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 441.67% | Etzer Darout50% | $3.25 → $3.25 | Reiterates | Market Perform → Market Perform | Get Alert |
| 04/26/2024 | AZN | Buy Now | AstraZeneca | $77.07 | 6.4% | Etzer Darout50% | $80 → $82 | Maintains | Outperform | Get Alert |
| 04/26/2024 | ACRV | Buy Now | Acrivon Therapeutics | $5.36 | 366.42% | Etzer Darout50% | $18 → $25 | Maintains | Outperform | Get Alert |
| 04/24/2024 | NVS | Buy Now | Novartis | $112.03 | 3.54% | Etzer Darout50% | $114 → $116 | Maintains | Market Perform | Get Alert |
| 04/01/2024 | ACRV | Buy Now | Acrivon Therapeutics | $5.36 | 235.82% | Etzer Darout50% | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 03/21/2024 | BNTX | Buy Now | BioNTech | $98.96 | 24.29% | Etzer Darout50% | $127 → $123 | Maintains | Outperform | Get Alert |
| 03/15/2024 | TERN | Buy Now | Terns Pharma | $3.16 | 501.27% | Etzer Darout50% | $18 → $19 | Maintains | Outperform | Get Alert |
| 03/12/2024 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 441.67% | Etzer Darout50% | $3.3 → $3.25 | Maintains | Market Perform | Get Alert |
| 03/08/2024 | MGNX | Buy Now | Macrogenics | $2.21 | 985.97% | Etzer Darout50% | $18 → $24 | Maintains | Outperform | Get Alert |
| 03/04/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 472.69% | Etzer Darout50% | $16 → $26 | Maintains | Outperform | Get Alert |
| 02/29/2024 | MRUS | Buy Now | Merus | $46.39 | 25.03% | Etzer Darout50% | $49 → $58 | Maintains | Outperform | Get Alert |
| 02/28/2024 | NUVL | Buy Now | Nuvalent | $76.66 | 33.06% | Etzer Darout50% | $93 → $102 | Maintains | Outperform | Get Alert |
| 02/28/2024 | ARVN | Buy Now | Arvinas | $8.36 | 976.27% | Etzer Darout50% | $89 → $90 | Maintains | Outperform | Get Alert |
| 02/28/2024 | XNCR | Buy Now | Xencor | $12.52 | 171.57% | Etzer Darout50% | $38 → $34 | Maintains | Outperform | Get Alert |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $0.95 | 636.76% | Etzer Darout50% | $6 → $7 | Maintains | Market Perform | Get Alert |
| 02/23/2024 | NVS | Buy Now | Novartis | $112.03 | 1.76% | Etzer Darout50% | → $114 | Initiates | → Market Perform | Get Alert |
| 02/23/2024 | BNTX | Buy Now | BioNTech | $98.96 | 28.33% | Etzer Darout50% | → $127 | Initiates | → Outperform | Get Alert |
| 02/23/2024 | GMAB | Buy Now | Genmab | $20.20 | 137.62% | Etzer Darout50% | $46 → $48 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/12/2024 | AZN | Buy Now | AstraZeneca | $77.07 | 3.8% | Etzer Darout50% | $82 → $80 | Maintains | Outperform | Get Alert |
| 12/01/2023 | IMGN | Buy Now | Immunogen | — | — | Etzer Darout50% | → $31 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/10/2023 | ACRV | Buy Now | Acrivon Therapeutics | $5.36 | 347.76% | Etzer Darout50% | $25 → $24 | Maintains | Outperform | Get Alert |
| 11/09/2023 | FATE | Buy Now | Fate Therapeutics | $0.95 | 531.51% | Etzer Darout50% | $5.4 → $6 | Maintains | Market Perform | Get Alert |
| 11/03/2023 | CCCC | Buy Now | C4 Therapeutics | $2.10 | 661.9% | Etzer Darout50% | $18 → $16 | Maintains | Outperform | Get Alert |
| 10/19/2023 | NUVL | Buy Now | Nuvalent | $76.66 | 3.05% | Etzer Darout50% | $73 → $79 | Maintains | Outperform | Get Alert |
| 10/05/2023 | NUVL | Buy Now | Nuvalent | $76.66 | -4.77% | Etzer Darout50% | $52 → $73 | Maintains | Outperform | Get Alert |
| 09/01/2023 | IVA | Buy Now | Inventiva | $2.97 | 304.04% | Etzer Darout50% | → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | FATE | Buy Now | Fate Therapeutics | $0.95 | 468.36% | Etzer Darout50% | $6 → $5.4 | Maintains | Market Perform | Get Alert |
| 08/09/2023 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 431.67% | Etzer Darout50% | $3.15 → $3.19 | Maintains | Market Perform | Get Alert |
| 08/01/2023 | IMGN | Buy Now | Immunogen | — | — | Etzer Darout50% | $25 → $26 | Maintains | Outperform | Get Alert |
| 08/01/2023 | AZN | Buy Now | AstraZeneca | $77.07 | 7.69% | Etzer Darout50% | $81 → $83 | Maintains | Outperform | Get Alert |
| 05/08/2023 | TERN | Buy Now | Terns Pharma | $3.16 | 469.62% | Etzer Darout50% | → $18 | Initiates | → Outperform | Get Alert |
| 05/08/2023 | ACRV | Buy Now | Acrivon Therapeutics | $5.36 | 366.42% | Etzer Darout50% | → $25 | Initiates | → Outperform | Get Alert |
| 04/25/2023 | FHTX | Buy Now | Foghorn Therapeutics | $4.44 | 327.93% | Etzer Darout50% | $20 → $19 | Maintains | Outperform | Get Alert |
| 04/18/2023 | MRUS | Buy Now | Merus | $46.39 | 5.63% | Etzer Darout50% | $47 → $49 | Maintains | Outperform | Get Alert |
| 04/03/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | — | Etzer Darout50% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/16/2023 | MRUS | Buy Now | Merus | $46.39 | 1.31% | Etzer Darout50% | $46 → $47 | Maintains | Outperform | Get Alert |
| 03/14/2023 | SGEN | Buy Now | Seagen | — | — | Etzer Darout50% | $179 → $229 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/16/2023 | SGEN | Buy Now | Seagen | — | — | Etzer Darout50% | $177 → $179 | Maintains | Outperform | Get Alert |
| 01/30/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 186.34% | Etzer Darout50% | $12 → $13 | Maintains | Outperform | Get Alert |
| 01/06/2023 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 433.33% | Etzer Darout50% | $2.6 → $3.2 | Maintains | Market Perform | Get Alert |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $0.95 | 636.76% | Etzer Darout50% | $20 → $7 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/05/2023 | AZN | Buy Now | AstraZeneca | $77.07 | 6.4% | Etzer Darout50% | → $82 | Initiates | → Outperform | Get Alert |
| 01/05/2023 | FHTX | Buy Now | Foghorn Therapeutics | $4.44 | 350.45% | Etzer Darout50% | → $20 | Initiates | → Outperform | Get Alert |
| 11/16/2022 | IMGN | Buy Now | Immunogen | — | — | Etzer Darout50% | $17 → $19 | Maintains | Outperform | Get Alert |
| 11/14/2022 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 333.33% | Etzer Darout50% | $3 → $2.6 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2022 | MGNX | Buy Now | Macrogenics | $2.21 | 623.98% | Etzer Darout50% | $5.7 → $16 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/01/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 164.32% | Etzer Darout50% | $29 → $12 | Maintains | Outperform | Get Alert |
| 10/11/2022 | SGEN | Buy Now | Seagen | — | — | Etzer Darout50% | $177 → $178 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/12/2022 | FATE | Buy Now | Fate Therapeutics | $0.95 | 4846.85% | Etzer Darout50% | $50 → $47 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/12/2022 | MGNX | Buy Now | Macrogenics | $2.21 | 81% | Etzer Darout50% | $31 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/11/2022 | FATE | Buy Now | Fate Therapeutics | $0.95 | 4846.85% | Etzer Darout50% | → $47 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/11/2022 | MGNX | Buy Now | Macrogenics | $2.21 | 81% | Etzer Darout50% | $31 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 400% | Etzer Darout50% | $9 → $3 | Maintains | Outperform | Get Alert |
| 06/24/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 494.71% | Etzer Darout50% | → $27 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 1400% | Etzer Darout50% | → $9 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | EXEL | Buy Now | Exelixis | $36.36 | -22.99% | Etzer Darout50% | → $28 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | NUVL | Buy Now | Nuvalent | $76.66 | -63.48% | Etzer Darout50% | → $28 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | GMAB | Buy Now | Genmab | $20.20 | 71.93% | Etzer Darout50% | → $34.73 | Initiates | → Market Perform | Get Alert |
| 06/24/2022 | SGEN | Buy Now | Seagen | — | — | Etzer Darout50% | → $169 | Initiates | → Market Perform | Get Alert |
| 04/11/2022 | CCCC | Buy Now | C4 Therapeutics | $2.10 | 852.38% | Etzer Darout50% | $57 → $20 | Maintains | Outperform | Get Alert |
| 02/11/2022 | IMGN | Buy Now | Immunogen | — | — | Etzer Darout50% | — | Initiates | → Outperform | Get Alert |
| 02/11/2022 | XNCR | Buy Now | Xencor | $12.52 | — | Etzer Darout50% | — | Initiates | → Outperform | Get Alert |
| 02/11/2022 | MRUS | Buy Now | Merus | $46.39 | -3% | Etzer Darout50% | → $45 | Initiates | → Outperform | Get Alert |
| 02/11/2022 | MGNX | Buy Now | Macrogenics | $2.21 | 1302.71% | Etzer Darout50% | → $31 | Initiates | → Outperform | Get Alert |
| 02/03/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -30.41% | Etzer Darout50% | → $170 | Upgrade | Neutral → Buy | Get Alert |
| 07/12/2021 | VERV | Buy Now | Verve Therapeutics | $5.85 | 1335.9% | Etzer Darout50% | → $84 | Initiates | → Buy | Get Alert |
| 05/18/2021 | ONTX | Buy Now | Onconova Therapeutics | — | — | Etzer Darout50% | → $60 | Initiates | → Buy | Get Alert |
| 03/09/2021 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Etzer Darout50% | → $38 | Downgrade | Buy → Neutral | Get Alert |
| 02/26/2021 | AKRO | Buy Now | Akero Therapeutics | $43.53 | 24.05% | Etzer Darout50% | → $54 | Initiates | → Buy | Get Alert |
| 02/22/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -33.69% | Etzer Darout50% | → $162 | Downgrade | Buy → Neutral | Get Alert |
| 09/22/2020 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Etzer Darout50% | → $11 | Upgrade | Neutral → Buy | Get Alert |
| 09/22/2020 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | — | Etzer Darout50% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/22/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | Etzer Darout50% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/09/2020 | MIRM | Buy Now | Mirum Pharmaceuticals | $44.31 | -14.24% | Etzer Darout50% | $27 → $38 | Maintains | Buy | Get Alert |
| 08/04/2020 | IVA | Buy Now | Inventiva | $2.97 | 775.42% | Etzer Darout50% | → $26 | Initiates | → Buy | Get Alert |
| 06/01/2020 | MGNX | Buy Now | Macrogenics | $2.21 | — | Etzer Darout50% | — | Upgrade | Neutral → Buy | Get Alert |
| 02/20/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | Etzer Darout50% | → $66 | Initiates | → Buy | Get Alert |
| 11/20/2019 | MGNX | Buy Now | Macrogenics | $2.21 | — | Etzer Darout50% | — | Assumes | → Neutral | Get Alert |
| 11/20/2019 | CTMX | Buy Now | CytomX Therapeutics | $0.60 | 2566.67% | Etzer Darout50% | → $16 | Initiates | → Buy | Get Alert |
| 10/01/2019 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Etzer Darout50% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/12/2019 | MIRM | Buy Now | Mirum Pharmaceuticals | $44.31 | — | Etzer Darout50% | — | Initiates | → Buy | Get Alert |
| 04/12/2019 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Etzer Darout50% | → $24 | Initiates | → Buy | Get Alert |
| 03/28/2018 | ACRS | Buy Now | Aclaris Therapeutics | $1.58 | 3191.14% | Etzer Darout50% | $54 → $52 | Maintains | Outperform | Get Alert |
| 05/13/2015 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Etzer Darout50% | → $31 | Initiates | → Buy | Get Alert |
| 10/14/2013 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Etzer Darout50% | → $20 | Initiates | → Buy | Get Alert |
